Abstract
Pacritinib (VONJO (TM)) is an orally administered, small molecule kinase inhibitor being developed by CTI BioPharma for the treatment of myelofibrosis......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
